Vivo Capital, LLC Mei Pharma, Inc. Transaction History

Vivo Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$2.6 - $3.32 $2.12 Million - $2.71 Million	-816,956 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.46 - $4.27 $652,205 - $1.13 Million	-265,124 Reduced 24.5%	816,956 $2.55 Million
Q2 2020 Aug 14, 2020	SELL	$1.45 - $4.3 $12.6 Million - $37.4 Million	-8,702,342 Reduced 88.94%	1,082,080 $4.47 Million
Q1 2020 May 15, 2020	BUY	$0.75 - $2.55 $7.34 Million - $25 Million	9,784,422 New	9,784,422 $15.8 Million
Q3 2019 Nov 13, 2019	SELL	$1.48 - $2.52 $8.41 Million - $14.3 Million	-5,681,397 Closed	0 $0

Q2 2019 Aug 13, 2019	SELL	$2.45 - $3.32 $236,937 - $321,073	-96,709 Reduced 1.67%	5,681,397 $14.2 Million
Q3 2018 Nov 13, 2018	SELL	$3.39 - $4.61 $2.79 Million - $3.79 Million	-822,554 Reduced 12.46%	5,778,106 $24.9 Million
Q2 2018 Aug 10, 2018	BUY	$1.89 - $4.95 $12.5 Million - $32.7 Million	6,600,660 New	6,600,660 $26 Million

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $372M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.